Union Funds Exit Amgen, Teva Antitrust MDL
Teva Pharmaceuticals has settled its differences with the union funds making up the indirect purchase class in multidistrict litigation accusing it of hatching an illegal deal to remove a generic calcium-control...To view the full article, register now.
Already a subscriber? Click here to view full article